Skip to content
RESEARCH | QUALITY | RELIABILITY
Email Us
info@anuhpharma.com
Call Us
+91 22 6622 7575
GET A QUOTE
Home
About Us
Our Company
Our Team
Board of Directors
Csr
Awards
Manufacturing
Facility
Certification
Gallery
Research
Facility
Services
Gallery
Products
Active Pharmaceutical Ingredients
Corticosteroids
Investor Relations
Contact
Menu
Home
About Us
Our Company
Our Team
Board of Directors
Csr
Awards
Manufacturing
Facility
Certification
Gallery
Research
Facility
Services
Gallery
Products
Active Pharmaceutical Ingredients
Corticosteroids
Investor Relations
Contact
Notices
Home
»
Investor Relations
»
Notices
»
Page 5
Search ...
Results
2023-2024
Intimation for Trading Window Closure
March 13, 2024
Prior Intimation under Regulation 29 of the SEBI
March 13, 2024
Intimation for Trading Window Closureon 31st December 2023
March 13, 2024
Prior Intimation of Board Meeting on 10.11.2023
March 13, 2024
Intimation of Trading Window Closure
March 13, 2024
Prior Intimation of Board Meeting
March 13, 2024
2022-2023
Trading Window Closure Intimation
March 13, 2024
Board Meeting Prior Intimation
March 13, 2024
Intimation of Trading Window Closure
March 13, 2024
Prior Intimation of Board Meeting under Regulation 29
March 13, 2024
BSE Intimatiom for Trading Window Closure.pdf
March 13, 2024
Intimation of Trading Window Closure as per SEBI.
March 13, 2024
Prior Intimation under Regulation 29 of the SEBI
March 13, 2024
Trading window closure – December
March 13, 2024
BSE Intimation Prior_07112022
March 13, 2024
2021-2022
Notice of Board Meeting to be held on 04.02.2022
March 13, 2024
Notice of Trading Window Closure from 31.12.2021
March 13, 2024
Notice of Board Meeting – 10.11.2021
March 13, 2024
Notice of Closure of Trading Window Closure from 30.09.2021
March 13, 2024
Notice of Board Meeting – 06.08.2021
March 13, 2024
Notice of Closure of Trading Window Closure
March 13, 2024
Notice of Board Meeting – 21.05.2021
March 13, 2024
2020-2021
Notice of Board Meeting – 07.08.2020
March 13, 2024
Intimation of Trading Window Closure from 01.07.2020
March 13, 2024
Notice of Board Meeting & Trading Window Closure
March 13, 2024
Intimation of Trading Window Closure from 01.04.2020
March 13, 2024
Intimation of Trading Window Closure from 31.03.2021
March 13, 2024
Notice of Board Meeting – 09.02.2021
March 13, 2024
Notice of Board Meeting – 06.11.2020
March 13, 2024
2019-2020
Notice of Board Meeting – 10.02.2020
March 13, 2024
Closure of Trading Window on 01.01.2020 for 48 Hrs
March 13, 2024
Notice of Board Meeting
March 13, 2024
Notice of Board Meeting – 07.08.2019
March 13, 2024
Notice of Board Meeting – 22.05.2019
March 13, 2024
Notice of Board Meeting – 21.02.2020
March 13, 2024
Prior Intimation Under Regulation 29
March 13, 2024
2018-2019
Notice of Board Meeting – 11.08.2018
March 13, 2024
Notice of Board Meeting 25.05.2018
March 13, 2024
Notice of Board Meeting – 08.02.2019
March 13, 2024
Notice of Board Meeting – 11.01.2019
March 13, 2024
Notice of Board Meeting & Trading Window Closure – 14.11.2018
March 13, 2024
2017-2018
Notice of Board Meeting – 07.12.2017
March 13, 2024
Notice of Board Meeting – 08.09.2017.pdf
March 13, 2024
Notice of Board Meeting – 09.08.2017
March 13, 2024
Notice of Board Meeting – 13.01.2017
March 13, 2024
Notice of Board Meeting – 13.02.2017
March 13, 2024
Notice of Board Meeting – 26.05.2017
March 13, 2024
Notice of Board Meeting 13.02.2018
March 13, 2024
Notice of Board Meeting 12.01.2018
March 13, 2024
2016-2017
Notice of Board Meeting – 05.01.2016
March 13, 2024
Notice of Board Meeting – 09.08.2016.pdf
March 13, 2024
Notice of Board Meeting – 11.11.2016
March 13, 2024
Notice of Board Meeting – 27.05.2016.pdf
March 13, 2024
Pseudo
Home
About Us
Our Company
Our Team
Board of Directors
Csr
Awards
Manufacturing
Facility
Certification
Gallery
Research
Facility
Services
Gallery
Products
Active Pharmaceutical Ingredients
Corticosteroids
Investor Relations
Contact
Home
About Us
Our Company
Our Team
Board of Directors
Csr
Awards
Manufacturing
Facility
Certification
Gallery
Research
Facility
Services
Gallery
Products
Active Pharmaceutical Ingredients
Corticosteroids
Investor Relations
Contact